2023 - Research.com Medicine in Spain Leader Award
Eduardo Tolosa focuses on Parkinson's disease, Dementia, Central nervous system disease, Internal medicine and Neuroscience. His Parkinson's disease research is classified as research in Disease. His Disease study combines topics in areas such as Dopamine, Pediatrics and Bioinformatics.
His Dementia research integrates issues from Progressive supranuclear palsy, Psychiatry, Hippocampus and Neuropsychology. His Central nervous system disease research includes themes of Mood and Subthalamic nucleus. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology.
His scientific interests lie mostly in Parkinson's disease, Internal medicine, Pathology, Disease and Neuroscience. His studies deal with areas such as Dementia, Central nervous system disease and Physical therapy as well as Parkinson's disease. His work carried out in the field of Dementia brings together such families of science as Movement disorders and Neuropsychology.
His Internal medicine study incorporates themes from Gastroenterology and Endocrinology. His Disease research incorporates themes from Genetics, Psychiatry, Pediatrics and Intensive care medicine. Eduardo Tolosa combines subjects such as Psychogenic disease, Magnetic resonance imaging and Audiology with his study of Neuroscience.
Parkinson's disease, Disease, Internal medicine, LRRK2 and REM sleep behavior disorder are his primary areas of study. His Parkinson's disease research is multidisciplinary, relying on both Physical medicine and rehabilitation, Neurodegeneration, Intensive care medicine, Parkinsonism and Neuroscience. In his study, Progressive supranuclear palsy is strongly linked to Neurology, which falls under the umbrella field of Parkinsonism.
His Disease research incorporates elements of Genetics, Psychiatry and Pediatrics. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Endocrinology. His REM sleep behavior disorder study integrates concerns from other disciplines, such as Rapid eye movement sleep and Dementia with Lewy bodies.
Eduardo Tolosa mainly focuses on Disease, Parkinson's disease, Pathology, Pediatrics and LRRK2. His Disease research is within the category of Internal medicine. His Parkinson's disease study combines topics from a wide range of disciplines, such as Apathy, Neurodegeneration and Neuroscience.
His research integrates issues of Rapid eye movement sleep and Magnetic resonance imaging in his study of Pathology. Eduardo Tolosa interconnects Adverse effect, Pharmacology, Constipation, Consensus criteria and Physical therapy in the investigation of issues within Pediatrics. His LRRK2 research is multidisciplinary, incorporating elements of Immunology and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G Healy;Mario Falchi;Sean S O'Sullivan;Vincenzo Bonifati.
Lancet Neurology (2008)
Criteria for the diagnosis of corticobasal degeneration.
Melissa J. Armstrong;Irene Litvan;Anthony E. Lang;Thomas H. Bak.
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
Bruno Dubois;David Burn;Christopher Goetz;Dag Aarsland;Dag Aarsland.
Movement Disorders (2007)
Parkinson's Disease and Movement Disorders
Joseph Jankovic;Eduardo Tolosa.
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin.
The New England Journal of Medicine (2009)
The diagnosis of Parkinson's disease
Eduardo Tolosa;Gregor Wenning;Werner Poewe.
Lancet Neurology (2006)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone;Werner Poewe;Stefan Albrecht;Catherine Debieuvre.
Lancet Neurology (2010)
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman.
Nature Genetics (2011)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.
Werner H Poewe;Olivier Rascol;Niall Quinn;Eduardo Tolosa.
Lancet Neurology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: